A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

Claudia Stäubert and her team of researchers at the University of Leipzig have just reported noteworthy findings which could impact the future treatment of inflammatory diseases. Lactic acid bacteria, or…

Continue Reading A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Cluster Seizures Approximately 1/3 of all epilepsy patients live with uncontrolled seizures. Of these, around 150,000 in the United States alone  experience cluster seizures (otherwise known as acute-repetitive seizures, crescendo…

Continue Reading A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

A New AS Study A recent study, published in Reumatologia aimed to evaluate how ankylosing spondylitis (AS) patients are coping with their condition on a psychological level. They wanted to investigate…

Continue Reading Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

To Know or Not to Know: Your Prerogative as Someone at Risk for Huntington’s Disease

Huntington's Disease Huntington's disease (HD) is a rare neurodegenerative disease. It progressively affects the patient's mobility and cognitive function. Unfortunately, a cure has yet to be discovered and the condition…

Continue Reading To Know or Not to Know: Your Prerogative as Someone at Risk for Huntington’s Disease

Finding Unbiased, Credible Information About Your Rare Disease Can Be Difficult, This Compilation of Resources May Help

When you or your child is first diagnosed with a rare disease it can be so difficult to know where to turn. You want to learn everything about the condition,…

Continue Reading Finding Unbiased, Credible Information About Your Rare Disease Can Be Difficult, This Compilation of Resources May Help

Phase 3 Trial Results Continue to Show the Efficacy of Orencia as a Treatment for Juvenile Idiopathic Arthritis

Orencia Orencia (abatacept) is a treatment for juvenile idiopathic arthritis (JIA) that was approved for use in the U.S. for the pediatric patient population in 2008. In Japan, the therapy…

Continue Reading Phase 3 Trial Results Continue to Show the Efficacy of Orencia as a Treatment for Juvenile Idiopathic Arthritis
England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen
source: pixabay.com

England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen

According to a publication from Express Digest, Britain's National Health Service (NHS) has finally reached an agreement with American biotechnology company Biogen Inc. over the price of Spinraza - a…

Continue Reading England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen
Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation
stevepb / Pixabay

Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Poseida Therapeutics, Inc. recently announced that the company's investigational product candidate P-BCMA-101 has been granted Orphan Drug Designation from the US…

Continue Reading Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation

Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

The Word "Rare" Unfortunately, many experts in rare disease believe the phrase "rare disease" may be harming the very population it describes. The Director of the National Center for Advancing…

Continue Reading Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear

According to a story from BioSpace, a Phase 1/2 clinical trial testing SGT-001, an investigational treatment for Duchenne muscular dystrophy, has been plagued by problems with side effects and adverse…

Continue Reading After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear

Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Coronado is a resort city located in San Diego, California. It's known for its luxury hotels, delicious restaurants, beautiful parks, and gorgeous beaches. It has just been announced that the…

Continue Reading Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

SCID Severe combined immunodeficiency (SCID) is a rare disease which causes patients to have little to no immune response. With practically no immune system, SCID patients are very susceptible to…

Continue Reading Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

The Origins of Fighting H.A.R.D. The Fighting H.A.R.D. Foundation was established in 2015 by two sisters who both live with multiple rare diagnoses. 16-year-old Allie is diagnosed with juvenile rheumatoid…

Continue Reading Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

PREFER PREFER stands for Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle. It is a multi-stage project developed by Newcastle University's Welcome Centre for Mitochondrial Research in effort…

Continue Reading The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy

Phage Therapy Phages, or bacteriophages, are the natural enemy of viruses. They are the most abundant organisms in the biosphere. Researchers have used phages as treatments before, however after the…

Continue Reading Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy

After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear

According to a story from BioSpace, a Phase 1/2 clinical trial testing SGT-001, an investigational treatment for Duchenne muscular dystrophy, has been plagued by problems with side effects and adverse…

Continue Reading After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear